Picture of Centene logo

CNC — Centene News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapSuper Stock

Centene Corp reports results for the quarter ended June 30 - Earnings Summary

Centene Corp reports results for the quarter ended June 30 - Earnings Summary
  • Centene Corp CNC.N reported quarterly adjusted earnings of $2.51​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -16 cents. The mean expectation of twenty one analysts for the quarter was for earnings of $1.09 per share. Wall Street expected results to range from 41 cents to $1.94 per share.

  • Revenue rose 9.9% to $53.58 billion from a year ago; analysts expected $47.62 billion.

  • Centene Corp's reported EPS for the quarter was $2.19​.

  • The company reported quarterly net income of $1.09 billion.

  • Centene Corp shares had fallen by 0.2% this quarter and gained 55.7% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 3.3% in the last three months.​

  • In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 8 "strong buy" or "buy," 14 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the managed healthcare peer group is "buy."

  • Wall Street's median 12-month price target for Centene Corp is $69.00, about 7.1% above its last closing price of $64.08

This summary was machine generated from LSEG data July 28 at 11:01 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2026

1.09

2.51

Beat

Mar. 31 2026

2.13

3.37

Beat

Dec. 31 2025

-1.22

-1.19

Beat

Sep. 30 2025

-0.14

0.50

Beat

Recent news on Centene

See all news